A neuroimaging biomarker for sustained experimental and clinical pain

被引:0
|
作者
Jae-Joong Lee
Hong Ji Kim
Marta Čeko
Bo-yong Park
Soo Ahn Lee
Hyunjin Park
Mathieu Roy
Seong-Gi Kim
Tor D. Wager
Choong-Wan Woo
机构
[1] Institute for Basic Science,Center for Neuroscience Imaging Research
[2] Sungkyunkwan University,Department of Biomedical Engineering
[3] University of Colorado,Institute of Cognitive Science
[4] University of Colorado,Department of Psychology and Neuroscience
[5] McGill University,McConnell Brain Imaging Centre, Montreal Neurological institute and Hospital
[6] Sungkyunkwan University,School of Electronic and Electrical Engineering
[7] McGill University,Department of Psychology
[8] McGill University,Alan Edwards Centre for Research on Pain
[9] Dartmouth College,Department of Psychological and Brain Sciences
[10] Sungkyunkwan University,Biomedical Institute for Convergence at SKKU
[11] Sungkyunkwan University,Department of Intelligent Precision Healthcare Convergence
来源
Nature Medicine | 2021年 / 27卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Sustained pain is a major characteristic of clinical pain disorders, but it is difficult to assess in isolation from co-occurring cognitive and emotional features in patients. In this study, we developed a functional magnetic resonance imaging signature based on whole-brain functional connectivity that tracks experimentally induced tonic pain intensity and tested its sensitivity, specificity and generalizability to clinical pain across six studies (total n = 334). The signature displayed high sensitivity and specificity to tonic pain across three independent studies of orofacial tonic pain and aversive taste. It also predicted clinical pain severity and classified patients versus controls in two independent studies of clinical low back pain. Tonic and clinical pain showed similar network-level representations, particularly in somatomotor, frontoparietal and dorsal attention networks. These patterns were distinct from representations of experimental phasic pain. This study identified a brain biomarker for sustained pain with high potential for clinical translation.
引用
收藏
页码:174 / 182
页数:8
相关论文
共 50 条
  • [41] Biomarker-Positive and -Negative Subjects in the Alzheimer's Disease Neuroimaging Initiative: Clinical Characterization
    Kennedy, Richard
    Schneider, Lon
    Cutter, Gary
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2011, 23 (02) : 11 - 11
  • [42] The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort
    Giesecke, T
    Gracely, RH
    Williams, DA
    Geisser, ME
    Petzke, FW
    Clauw, DJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (05): : 1577 - 1584
  • [43] CHRONIC PAIN AND DISTRACTION - AN EXPERIMENTAL INVESTIGATION INTO THE ROLE OF SUSTAINED AND SHIFTING ATTENTION IN THE PROCESSING OF CHRONIC PERSISTENT PAIN
    ECCLESTON, C
    BEHAVIOUR RESEARCH AND THERAPY, 1995, 33 (04) : 391 - 405
  • [44] The role of neuroimaging biomarker in drug discovery for schizophrenia
    Ozaki, Satoshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 22P - 22P
  • [45] Replication of a neuroimaging biomarker for striatal dysfunction in psychosis
    Rubio, Jose M.
    Lencz, Todd
    Cao, Hengyi
    Kraguljac, Nina
    Dhamala, Elvisha
    Homan, Philipp
    Horga, Guillermo
    Sarpal, Deepak K.
    Argyelan, Miklos
    Gallego, Juan
    Cholewa, John
    Barber, Anita
    Kane, John M.
    Malhotra, Anil K.
    MOLECULAR PSYCHIATRY, 2024, 29 (04) : 929 - 938
  • [46] Towards a neuroimaging biomarker for amyotrophic lateral sclerosis
    Turner, Martin R.
    Grosskreutz, Julian
    Kassubek, Jan
    Abrahams, Sharon
    Agosta, Federica
    Benatar, Michael
    Filippi, Massimo
    Goldstein, Laura H.
    van den Heuvel, Martijn
    Kalra, Sanjay
    Lule, Dorothee
    Mohammadi, Bahram
    Atassi, Nazem
    Bede, Peter
    Benali, Habib
    Enzinger, Christian
    Gaser, Christian
    Jelsone-Swain, Laura
    Mueller, Hans-Peter
    Orrell, Richard W.
    Pradat, Pierre-Francois
    Prudlo, Johannes
    Ropele, Stefan
    Sharma, Rakesh
    Silani, Vincenzo
    Simmons, Andrew
    Smith, Stephen
    Teipel, Stefan
    Toosy, Ahmed
    Tsermentseli, Stella
    Van Damme, Philip
    Verstraete, Esther
    Welsh, Robert
    Wittstock, Matthias
    LANCET NEUROLOGY, 2011, 10 (05): : 400 - 403
  • [47] Replication of a Neuroimaging Biomarker for Striatal Dysfunction in Psychosis
    Rubio, Jose
    Lencz, Todd
    Cao, Hengyi
    Kraguljac, Nina
    Dhamala, Elvisha
    Homan, Philipp
    Horga, Guillermo
    Sarpal, Deepak
    Argyelan, Miklos
    Gallego, Juan
    Cholewa, John
    Barber, Anita
    Kane, John
    Malhotra, Anil
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 374 - 375
  • [48] Neuroimaging-based biomarker discovery and validation
    Woo, Choong-Wan
    Wager, Tor D.
    PAIN, 2015, 156 (08) : 1379 - 1381
  • [49] Certainly Not the First Neuroimaging Treatment Selection Biomarker
    Henderson, Theodore
    Tarzwell, Robert
    JAMA PSYCHIATRY, 2014, 71 (02) : 210 - 211
  • [50] Neuroimaging in psychiatry: an update on neuroimaging in the clinical setting
    Power, Brian D.
    Nguyen, T.
    Hayhow, B.
    Looi, J. C. L.
    AUSTRALASIAN PSYCHIATRY, 2016, 24 (02) : 157 - 163